We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$450M
AUM Growth
+$22.2M
Cap. Flow
-$22.2M
Cap. Flow %
-4.93%
Top 10 Hldgs %
56.42%
Holding
36
New
3
Increased
16
Reduced
10
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 91.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MASI
26
DELISTED
Masimo
MASI
$7.41M 1.65%
+281,423
New +$6.95M
MDCO
27
DELISTED
Medicines Co
MDCO
$7.29M 1.62%
263,450
+108,000
+69% +$2.68M
CYH icon
28
Community Health Systems
CYH
$440M
$7.12M 1.58%
159,841
+25,531
+19% +$1.09M
ACOR
29
DELISTED
Acorda Therapeutics
ACOR
$3.47M 0.77%
708
-764
-52% -$3.28M
SPPI
30
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$482K 0.11%
69,500
CTRX
31
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
-113,500
Closed -$4.78M
VOLC
32
DELISTED
VOLCANO CORPORATION COM STK
VOLC
-557,000
Closed -$5.93M
AUXL
33
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
-85,920
Closed -$2.56M
CBST
34
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
-199,990
Closed -$13.3M
AVNR
35
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
-229,400
Closed -$2.73M
AGN
36
DELISTED
Allergan Inc
AGN
-20,000
Closed -$3.56M

Similar funds

Sector Gamma AS's Q4 2014 Portfolio in Review

As of Q4 2014, Sector Gamma AS held 36 positions worth $450M, up 5.2% from $427M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sector Gamma AS withdrew a net $22.2M in Q4 2014, closing 6 positions and reducing 10 holdings. Its most notable exit was CUBIST PHARMACEUTICALS INC, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 86% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Viatris worth $14.5M.

  • Sector Gamma AS's largest Q4 2014 buy was Viatris: 256,600 shares worth $14.5M.
  • Sector Gamma AS added most to Baxter International in Q4 2014, an estimated $5.89M increase.
  • Sector Gamma AS's biggest Q4 2014 reduction was Eli Lilly, cutting an estimated $15M.
  • Sector Gamma AS fully exited CUBIST PHARMACEUTICALS INC in Q4 2014, selling an estimated $13.3M.
  • Sector Gamma AS's ten largest holdings make up 56% of its $450M portfolio in Q4 2014.
  • Sector Gamma AS opened 3 new positions and closed 6 in Q4 2014.
  • Sector Gamma AS's portfolio value rose 5.2% quarter-over-quarter to $450M.

Based on Sector Gamma AS's 13F filing for Q4 2014, filed 17 Feb 2015.